UNSPSC 51381511: Glafenine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51381511

Definition

This classification denotes an analgesic agent with the molecular formula C19H17ClN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 46HL4I09AH, chemically known as 2,3-dihydroxypropyl n-(7-chloro-4-quinolyl) anthranilate but generally known as glafenine, which bears US NIH Compound Identifier 3474. European Medicines Agency schedules Glafenine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07909MIG. The term GLAFENINE is an International Non-Proprietary Name.

Read the full definition

World Health Organization schedules glafenine in its Anatomical Therapeutic Chemical (ATC) Classification. GLAFENINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule glafenine under HS 29334990 and SITC 51575. As of Q4 2014, GLAFENINE remains the US FDA Preferred Term for this commodity. Glafenine bears US NLM identifiers UMLS ID C0017592 and NCI Concept Code C72119. SMILES: CLC1CC2NCCC(NC3C(C(=O)OCC(O)CO)CCCC3)C2CC1.

About UNSPSC 51381511

UNSPSC 51381511 Glafenine is a Commodity code that, based on recent state and local solicitations, appears to be applied to emergency response pharmaceuticals and harm-reduction equipment rather than glafenine specifically. The recent opportunity on file—Seminole County, Florida's procurement of naloxone and drug deactivation systems—indicates that the code is being used in practice to tag purchases of opioid antagonists and overdose-reversal supplies for public health and emergency management purposes. State and local health departments and county emergency services are the primary issuing bodies under this code. Naloxone procurement is typically driven by community health initiatives, overdose response programs, and compliance with state or federal harm-reduction mandates. Vendors supplying under this code must meet standard compliance requirements including E-Verify eligibility verification, drug-free workplace certification, and appropriate insurance coverage.

Recent activity is concentrated in Florida, specifically Seminole County, which released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023. Quarterly deliveries are required to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs. The initial contract term is two years with an option for one-year renewal. Potential FEMA funding introduces additional federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act. The source reflects limited recent opportunities; this represents the only posting available for analysis under this code.

Quick answers

What is UNSPSC 51381511?

UNSPSC 51381511 is Glafenine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51381511?

UNSPSC 51381511 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51381511

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code